Faouzi Djebbari, MPharm (Hons), MSc, of Oxford University Hospitals NHS Trust, Oxford, UK, discusses his work investigating the risk of lenalidomide toxicity in older patients with relapsed multiple myeloma. He also highlights his plans for further study in this area. This interview was recorded at the UK Oncology Nursing Society (UKONS) 2018 Annual Conference, held in Glasgow, UK.
15 ноя 2018
